Bilateral Synchronous Breast Cancer and HER-2/ neu Overexpression

Author： Safa Malek   Lower Elyse   Hasselgren P.O.   Hungness Eric   Gazder Paula   Aron Bernard   Shaughnessy Elizabeth   Yassin Rawia  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.72, Iss.3, 2002-04, pp. : 195-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer

By Konecny G.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 53-63

Springer Publishing Company

Access to resources Recommend Favorite

Her-2/ neu and Topoisomerase iiα in Breast Cancer

By Järvinen T.A.H.  

Breast Cancer Research and Treatment, Vol. 78, Iss. 3, 2003-04 ,pp. : 299-311

Springer Publishing Company

Access to resources Recommend Favorite

Influence of Neoadjuvant Therapy with Epirubicin and Docetaxel on the Expression of HER2/ neu in Patients with Breast Cancer

By Taucher Susanne  

Breast Cancer Research and Treatment, Vol. 82, Iss. 3, 2003-01 ,pp. : 207-213

Springer Publishing Company

Access to resources Recommend Favorite

Her-2/ neu Gene Amplification and Protein Expression in Primary Male Breast Cancer

By Rudlowski Christian  

Breast Cancer Research and Treatment, Vol. 84, Iss. 3, 2004-04 ,pp. : 215-223

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/ neu expression in primary and metastatic breast cancer

By Lower Elyse  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 301-306

Springer Publishing Company

Access to resources Recommend Favorite